13D/13G Filings - Arch Therapeutics Inc. (ARTH)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-13
5:18 pm
Purchase		 2024-09-30 13G Arch Therapeutics, Inc.
ARTH		 Bigger Capital LLC 300,000
6.800%		 300,000increase
(New Position)		 Filing
History
2024-01-22
12:39 pm
Purchase		 2023-12-31 13G Arch Therapeutics, Inc.
ARTH		 Parker Michael Andrew 213,529
4.500%		 107,340increase
(+101.08%)		 Filing
History
2023-08-09
11:16 am
Purchase		 2023-07-12 13G Arch Therapeutics, Inc.
ARTH		 Stahl Andrew 300,000
9.890%		 300,000increase
(New Position)		 Filing
History
2023-07-25
2:47 pm
Purchase		 2023-07-12 13G Arch Therapeutics, Inc.
ARTH		 wilson brandt 300,000
9.890%		 300,000increase
(New Position)		 Filing
History
2023-07-14
09:00 am
Purchase		 2023-07-12 13G Arch Therapeutics, Inc.
ARTH		 BIGGER CAPITAL FUND L P 300,000
9.900%		 300,000increase
(New Position)		 Filing
History
2023-07-12
5:00 pm
Purchase		 2023-07-12 13G Arch Therapeutics, Inc.
ARTH		 Oasis Capital LLC 303,142
9.990%		 303,142increase
(New Position)		 Filing
History
2023-01-27
2:18 pm
Unchanged		 2022-12-31 13G Arch Therapeutics, Inc.
ARTH		 Parker Michael Andrew 106,189
8.497%		 0
(Unchanged)		 Filing
History
2023-01-25
3:18 pm
Purchase		 2022-12-31 13G Arch Therapeutics, Inc.
ARTH		 Parker Michael Andrew 106,189
8.497%		 106,189increase
(New Position)		 Filing
History
2022-01-12
10:07 am
Purchase		 2021-12-31 13G Arch Therapeutics, Inc.
ARTH		 Parker Michael Andrew 4,194,140,000
8.840%		 1,100,574,000increase
(+35.58%)		 Filing
History
2021-01-22
5:27 pm
Purchase		 2020-12-31 13G Arch Therapeutics, Inc.
ARTH		 Parker Michael Andrew 3,093,566,000
8.010%		 244,707,800increase
(+8.59%)		 Filing
History